June 13, 2025 02:16 PM EDT
Pharma
FDA+

FDA's on­col­o­gy ad­comm to re­view GSK's Blenrep re­launch plans

Nicole DeFeudis

Editor

The FDA’s On­co­log­ic Drugs Ad­vi­so­ry Com­mit­tee will meet on Ju­ly 17 to dis­cuss a po­ten­tial re­launch of GSK’s mul­ti­ple myelo­ma drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

Bris­tol My­ers gets a key strate­gist with 'Team Shib­s'; Idor­sia to change CEOs af­ter it 'hit a re­set but­ton'

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

sponsored

McKesson leads the charge in rev­o­lu­tion­iz­ing pre­ci­sion on­col­o­gy in com­mu­ni­ty prac­tices

A service from the Financial Times